UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients

Breast cancer research and treatment, 2014-02, Vol.144 (1), p.143-152

2014

Volltextzugriff (PDF)

Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study

The lancet oncology, 2020-11, Vol.21 (11), p.1423-1432

2020

Volltextzugriff (PDF)

Population Pharmacokinetics and Pharmacodynamics of Doxorubicin and Cyclophosphamide in Breast Cancer Patients : A Study by the EORTC-PAMM-NDDG

Clinical pharmacokinetics, 2007-01, Vol.46 (12), p.1051-1068

2007

Volltextzugriff (PDF)

One-Pot Fabrication of Hollow Porphyrinic MOF Nanoparticles with Ultrahigh Drug Loading toward Controlled Delivery and Synergistic Cancer Therapy

ACS applied materials & interfaces, 2021-01, Vol.13 (3), p.3679-3693

2021

Volltextzugriff (PDF)

ROS-sensitive thioketal-linked polyphosphoester-doxorubicin conjugate for precise phototriggered locoregional chemotherapy

Biomaterials, 2019-01, Vol.188, p.74-82

2019

Volltextzugriff (PDF)

Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy

Acta biomaterialia, 2019-01, Vol.84, p.367-377

2019

Volltextzugriff (PDF)

Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients

Pharmacogenomics, 2007-06, Vol.8 (6), p.567-575

2007

Volltextzugriff (PDF)

H-ferritin–nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection

Proceedings of the National Academy of Sciences - PNAS, 2014-10, Vol.111 (41), p.14900-14905

2014

Volltextzugriff (PDF)

Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release

Biomaterials, 2016-01, Vol.75, p.193-202

2016

Volltextzugriff (PDF)

Drug Delivery with PEGylated MoS2 Nano-sheets for Combined Photothermal and Chemotherapy of Cancer

Advanced materials (Weinheim), 2014-06, Vol.26 (21), p.3433-3440

2014

Volltextzugriff (PDF)

Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin

Journal of controlled release, 2015-12, Vol.220 (Pt A), p.275-286

2015

Volltextzugriff (PDF)

cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo

Journal of controlled release, 2016-07, Vol.233, p.29-38

2016

Volltextzugriff (PDF)

Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy

Journal of controlled release, 2018-07, Vol.282, p.46-61

2018

Volltextzugriff (PDF)

Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)

PloS one, 2014-01, Vol.9 (1), p.e82331

2014

Volltextzugriff (PDF)

ATP-triggered anticancer drug delivery

Nature communications, 2014-03, Vol.5 (1), p.3364-3364, Article 3364

2014

Volltextzugriff (PDF)

An injectable nanoparticle generator enhances delivery of cancer therapeutics

Nature biotechnology, 2016-04, Vol.34 (4), p.414-418

2016

Volltextzugriff (PDF)

Phase-Change Material Packaged within Hollow Copper Sulfide Nanoparticles Carrying Doxorubicin and Chlorin e6 for Fluorescence-Guided Trimodal Therapy of Cancer

ACS applied materials & interfaces, 2019-01, Vol.11 (1), p.417-429

2019

Volltextzugriff (PDF)

Stimuli-responsive polymer-doxorubicin conjugate: Antitumor mechanism and potential as nano-prodrug

Acta biomaterialia, 2019-01, Vol.84, p.339-355

2019

Volltextzugriff (PDF)

Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy

Journal of controlled release, 2017-07, Vol.258, p.43-55

2017

Volltextzugriff (PDF)

Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles

Nanoscale, 2016-04, Vol.8 (13), p.6948-6957

2016

Volltextzugriff (PDF)

pH-sensitive doxorubicin-conjugated prodrug micelles with charge-conversion for cancer therapy

Acta biomaterialia, 2018-04, Vol.70, p.186-196

2018

Volltextzugriff (PDF)

Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy

Journal of controlled release, 2014-06, Vol.183, p.18-26

2014

Volltextzugriff (PDF)

Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapy

Journal of controlled release, 2017-10, Vol.264, p.89-101

2017

Volltextzugriff (PDF)

Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer

Journal of controlled release, 2018-12, Vol.291, p.184-195

2018

Volltextzugriff (PDF)

Co-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacy

European journal of pharmaceutics and biopharmaceutics, 2017-03, Vol.112, p.209-223

2017

Volltextzugriff (PDF)

1 – 25 von 1.537

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.456)
Mit Volltextzugriff
(1.304)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.353)
Life Sciences & Biomedicine
(1.183)
Humans
(1.152)
Doxorubicin - Pharmacokinetics
(1.143)
Animals
(897)
Doxorubicin - Administration & Dosage
(832)
Mice
(612)
Biological And Medical Sciences
(581)
Medical Sciences
(579)
Pharmacology & Pharmacy
(568)
Oncology
(548)
Doxorubicin
(539)
Pharmacology. Drug Treatments
(504)
Male
(472)
Antibiotics, Antineoplastic - Pharmacokinetics
(454)
Antineoplastic Agents
(400)
Chemotherapy
(398)
Cell Line, Tumor
(393)
Middle Aged
(393)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.537)
Ingenta
(768)
EZB Free E-Journals
(597)
Ovid
(515)
Elsevier ScienceDirect Journals Complete
(361)
Single Journals
(300)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(291)
IngentaConnect Journals
(280)
Springer Journals
(257)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(214)
Wiley Online Library
(141)
Taylor & Francis Journals Auto-Holdings Collection
(110)
Wiley Online Library
(102)
Taylor & Francis
(84)
Taylor & Francis:Master (3349 titles)
(77)
Nature
(68)
Nexis Uni
(37)
Oxford University Press Journals Current
(28)
SpringerLink Series
(22)
Oxford Journals 2020 Medicine
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients

Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study

Population Pharmacokinetics and Pharmacodynamics of Doxorubicin and Cyclophosphamide in Breast Cancer Patients : A Study by the EORTC-PAMM-NDDG

One-Pot Fabrication of Hollow Porphyrinic MOF Nanoparticles with Ultrahigh Drug Loading toward Controlled Delivery and Synergistic Cancer Therapy

ROS-sensitive thioketal-linked polyphosphoester-doxorubicin conjugate for precise phototriggered locoregional chemotherapy

Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy

Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients

H-ferritin–nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection

Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release

Drug Delivery with PEGylated MoS2 Nano-sheets for Combined Photothermal and Chemotherapy of Cancer

Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin

cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo

Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy

Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)

ATP-triggered anticancer drug delivery

An injectable nanoparticle generator enhances delivery of cancer therapeutics

Phase-Change Material Packaged within Hollow Copper Sulfide Nanoparticles Carrying Doxorubicin and Chlorin e6 for Fluorescence-Guided Trimodal Therapy of Cancer

Stimuli-responsive polymer-doxorubicin conjugate: Antitumor mechanism and potential as nano-prodrug

Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy

Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles

pH-sensitive doxorubicin-conjugated prodrug micelles with charge-conversion for cancer therapy

Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy

Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapy

Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer

Co-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacy

Aktive Filter

Suchergebnisse filtern